CLINICAL_TRIALS
trial_result
· 2014-12-22
Clinical Trial Update: Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection
Summary
A completed clinical trial investigated once-daily Kaletra (lopinavir/ritonavir) tablets in HIV infection, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Human Immunodeficiency Virus Infection | Status: COMPLETED | Results posted: 2014-12-22